Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
67.41
+2.24 (3.44%)
Oct 6, 2025, 3:11 PM EDT - Market open
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 323 employees as of December 31, 2024. The number of employees increased by 79 or 32.38% compared to the previous year.
Employees
323
Change (1Y)
79
Growth (1Y)
32.38%
Revenue / Employee
$914,926
Profits / Employee
-$284,808
Market Cap
2.85B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 323 | 79 | 32.38% |
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TARS News
- 10 days ago - Tarsus Pharmaceuticals: Considering If The Big Marketing Push Will Pay Off - Seeking Alpha
- 5 weeks ago - Tarsus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Top 2 Health Care Stocks That May Fall Off A Cliff In August - Benzinga
- 2 months ago - Tarsus Pharmaceuticals, Inc. (TARS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements - GlobeNewsWire
- 2 months ago - Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - GlobeNewsWire
- 5 months ago - Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off - Seeking Alpha
- 5 months ago - Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown - PRNewsWire